These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 19256738)

  • 1. Effect of change in symptoms, respiratory status, nutritional profile and quality of life on response to treatment for advanced non-small cell lung cancer.
    Mohan A; Singh P; Kumar S; Mohan C; Pathak AK; Pandey RM; Guleria R
    Asian Pac J Cancer Prev; 2008; 9(4):557-62. PubMed ID: 19256738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality-of-life outcomes for adjuvant chemotherapy in early-stage non-small-cell lung cancer: results from a randomized trial, JBR.10.
    Bezjak A; Lee CW; Ding K; Brundage M; Winton T; Graham B; Whitehead M; Johnson DH; Livingston RB; Seymour L; Shepherd FA
    J Clin Oncol; 2008 Nov; 26(31):5052-9. PubMed ID: 18809617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating quality of life and pulmonary function of long-term survivors of non-small cell lung cancer treated with radical or postoperative radiotherapy.
    Ozturk A; Sarihan S; Ercan I; Karadag M
    Am J Clin Oncol; 2009 Feb; 32(1):65-72. PubMed ID: 19194128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life results from the phase 3 REVEL randomized clinical trial of ramucirumab-plus-docetaxel versus placebo-plus-docetaxel in advanced/metastatic non-small cell lung cancer patients with progression after platinum-based chemotherapy.
    Pérol M; Ciuleanu TE; Arrieta O; Prabhash K; Syrigos KN; Goksel T; Park K; Kowalyszyn RD; Pikiel J; Lewanski CR; Thomas M; Dakhil S; Kim JH; Karaseva N; Yurasov S; Zimmermann A; Lee P; Carter GC; Reck M; Cappuzzo F; Garon EB
    Lung Cancer; 2016 Mar; 93():95-103. PubMed ID: 26898621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptom and quality of life benefit of afatinib in advanced non-small-cell lung cancer patients previously treated with erlotinib or gefitinib: results of a randomized phase IIb/III trial (LUX-Lung 1).
    Hirsh V; Cadranel J; Cong XJ; Fairclough D; Finnern HW; Lorence RM; Miller VA; Palmer M; Yang JC
    J Thorac Oncol; 2013 Feb; 8(2):229-37. PubMed ID: 23328549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life as a clinical trial endpoint: determining the appropriate interval for repeated assessments in patients with advanced lung cancer.
    Hollen PJ; Gralla RJ; Rittenberg CN
    Support Care Cancer; 2004 Nov; 12(11):767-73. PubMed ID: 15206013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of quality of life associated with standard chemotherapy regimens for advanced non-small cell lung cancer.
    Tanvetyanon T; Soares HP; Djulbegovic B; Jacobsen PB; Bepler G
    J Thorac Oncol; 2007 Dec; 2(12):1091-7. PubMed ID: 18090580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II study of docetaxel and carboplatin in Thai patients with advanced non-small-cell lung cancer.
    Thongprasert S; Soorraritchingchai S; Chewaskulyong B; Charoentum C; Munprakan S
    J Med Assoc Thai; 2006 Feb; 89(2):152-9. PubMed ID: 16579000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of chronic obstructive pulmonary disease on respiratory status and quality of life in newly diagnosed patients with lung cancer.
    Mohan A; Mohan C; Pathak AK; Pandey RM; Guleria R
    Respirology; 2007 Mar; 12(2):240-7. PubMed ID: 17298457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients-Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study.
    Takayama K; Atagi S; Imamura F; Tanaka H; Minato K; Harada T; Katakami N; Yokoyama T; Yoshimori K; Takiguchi Y; Hataji O; Takeda Y; Aoe K; Kim YH; Yokota S; Tabeta H; Tomii K; Ohashi Y; Eguchi K; Watanabe K
    Support Care Cancer; 2016 Aug; 24(8):3473-80. PubMed ID: 27003901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-line cisplatin with docetaxel or vinorelbine in patients with advanced non-small-cell lung cancer: a quality of life directed phase II randomized trial of Gruppo Oncologico Italia Meridionale.
    Gebbia V; Lorusso V; Galetta D; Caruso M M; Palomba G; Riccardi F; Borsellino N; Carrozza F; Leo S; Ferraù F; Cinieri S; Mancuso G; Mancarella S; Colucci G
    Lung Cancer; 2010 Aug; 69(2):218-24. PubMed ID: 19910076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung cancer.
    Feigenberg SJ; Hanlon AL; Langer C; Goldberg M; Nicolaou N; Millenson M; Coia LR; Lanciano R; Movsas B
    J Thorac Oncol; 2007 Apr; 2(4):287-92. PubMed ID: 17409799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of docetaxel and carboplatin in elderly patients with advanced non-small cell lung cancer.
    Yoshimura N; Kudoh S; Kimura T; Mitsuoka S; Kyoh S; Tochino Y; Asai K; Kodama T; Ichimaru Y; Yana T; Hirata K
    J Thorac Oncol; 2009 Mar; 4(3):371-5. PubMed ID: 19155998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial.
    Thatcher N; Hirsch FR; Luft AV; Szczesna A; Ciuleanu TE; Dediu M; Ramlau R; Galiulin RK; Bálint B; Losonczy G; Kazarnowicz A; Park K; Schumann C; Reck M; Depenbrock H; Nanda S; Kruljac-Letunic A; Kurek R; Paz-Ares L; Socinski MA;
    Lancet Oncol; 2015 Jul; 16(7):763-74. PubMed ID: 26045340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Impact of erlotinib treatment on symptoms and quality of life in patients with advanced non-small-cell lung cancer].
    Zhou SW; Ren SX; Yan LH; Zhang L; Zhou CC
    Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):469-72. PubMed ID: 19024526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancer.
    Brown J; Thorpe H; Napp V; Fairlamb DJ; Gower NH; Milroy R; Parmar MK; Rudd RM; Spiro SG; Stephens RJ; Waller D; West P; Peake MD
    J Clin Oncol; 2005 Oct; 23(30):7417-27. PubMed ID: 16157935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life, symptom status and physical performance in patients with advanced non-small cell lung cancer undergoing chemotherapy: an exploratory analysis of secondary data.
    Shallwani SM; Simmonds MJ; Kasymjanova G; Spahija J
    Lung Cancer; 2016 Sep; 99():69-75. PubMed ID: 27565917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase III trial comparing vinflunine with docetaxel in second-line advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy.
    Krzakowski M; Ramlau R; Jassem J; Szczesna A; Zatloukal P; Von Pawel J; Sun X; Bennouna J; Santoro A; Biesma B; Delgado FM; Salhi Y; Vaissiere N; Hansen O; Tan EH; Quoix E; Garrido P; Douillard JY
    J Clin Oncol; 2010 May; 28(13):2167-73. PubMed ID: 20351334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chemotherapy for advanced non-small cell lung cancer on patients' quality of life. A randomized controlled trial.
    Belani CP; Pereira JR; von Pawel J; Pluzanska A; Gorbounova V; Kaukel E; Mattson KV; Ramlau R; Szczesna A; Fidias P; Millward M; Fossella F;
    Lung Cancer; 2006 Aug; 53(2):231-9. PubMed ID: 16787687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of respiratory symptoms and pulmonary function on quality of life of long-term survivors of non-small cell lung cancer.
    Sarna L; Evangelista L; Tashkin D; Padilla G; Holmes C; Brecht ML; Grannis F
    Chest; 2004 Feb; 125(2):439-45. PubMed ID: 14769722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.